Melanie Story
Family Medicine · Louisville, KYNPI 1447203724
Payments from drug & device makers
Across 285 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$719
- Novo Nordisk$699
- IBSA Pharma Inc.$556
- Lilly USA, LLC$393
- Amgen$323
- AbbVie$310
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,51199%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 47 | $719 |
| Novo Nordisk | 44 | $699 |
| IBSA Pharma Inc. | 32 | $556 |
| Lilly USA, LLC | 25 | $393 |
| Amgen | 19 | $323 |
| AbbVie | 23 | $310 |
| GSK | 17 | $301 |
| Amarin Pharma, Inc. | 19 | $296 |
| Novartis | 10 | $170 |
| Exact Sciences | 6 | $111 |
| Currax Pharmaceuticals LLC | 6 | $79 |
| Abbott | 4 | $62 |
| Merck | 2 | $51 |
| Amneal Pharmaceuticals LLC | 3 | $49 |
| Endo Pharmaceuticals Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Esperion Therapeutics, Inc. | 3 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Eisai Inc. | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $28 |
| AstraZeneca | 2 | $27 |
| Bausch Health US, LLC | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $12 |
How this compares
$4,561 in reported general payments places this provider in the 80th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $82,938 |
| MounjaroTirzepatide | 42 | $60,678 |
| Repatha SureclickEvolocumab | 56 | $52,890 |
| EliquisApixaban | 24 | $30,959 |
| VascepaIcosapent Ethyl | 61 | $25,117 |
| XareltoRivaroxaban | 13 | $19,172 |
| JardianceEmpagliflozin | 11 | $17,657 |
| SynthroidLevothyroxine Sodium | 55 | $5,384 |
| TirosintLevothyroxine Sodium | 19 | $3,625 |
| Esomeprazole Magnesium | 24 | $1,950 |
| Rosuvastatin Calcium | 201 | $1,849 |
| Tirosint-SolLevothyroxine Sodium | 11 | $1,526 |
| Levothyroxine Sodium | 88 | $1,225 |
| Nebivolol Hcl | 26 | $1,175 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $1,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $699 | $82,93870 claims |
| Lilly USA, LLCMounjaro | $393 | $60,67842 claims |
| PfizerEliquis | $15 | $30,95924 claims |
| Boehringer IngelheimJardiance | $13 | $17,65711 claims |
| AbbVieSynthroid | $310 | $5,38455 claims |
| IBSA Pharma Inc.Tirosint, Tirosint-Sol | $556 | $5,15130 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $49 | $1,22588 claims |
| Almatica Pharma LLCSertraline Hcl | $28 | $13415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Louisville
- Christopher RhyneLouisville$1M
- Michael LovelaceLouisville$244K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- Rajanbhai AminLouisville$26K
- James WrightLouisville$18K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.